Magee Thomson Investment Partners’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Magee Thomson Investment Partners’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-96	Closed	-$4K	–	117
2016 Q1	$4K	Sell	96 -19	-17%	-$697	﹤0.01%	82
2015 Q4	$5K	Sell	115 -15	-12%	-$752	﹤0.01%	65
2015 Q3	$5K	Sell	130 -22	-14%	-$1.19K	﹤0.01%	62
2015 Q2	$8K	Buy	152 +11	+8%	+$469	﹤0.01%	37
2015 Q1	$5K	Buy	141 +16	+13%	+$627	﹤0.01%	71
2014 Q4	$5K	Buy	+125	New	+$4.77K	﹤0.01%	131

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Magee Thomson Investment Partners's BSTC Position: Q2 2016 in Review

Magee Thomson Investment Partners sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2016, closing a stake of 96 shares — an estimated $4K sold.

Magee Thomson Investment Partners first reported a position in BSTC in Q4 2014 and held it in 6 quarters. The position peaked at $8K in Q2 2015. 90 funds tracked by Wall St. Rank hold BSTC as of Q2 2016.

Magee Thomson Investment Partners reported no remaining BioSpecifics Technologies Corp. position as of Q2 2016 after selling out during the quarter.
Magee Thomson Investment Partners sold 96 BioSpecifics Technologies Corp. shares in Q2 2016, an estimated $4K.
Magee Thomson Investment Partners first reported a position in BioSpecifics Technologies Corp. in Q4 2014 and held it in 6 quarters.
Magee Thomson Investment Partners's BioSpecifics Technologies Corp. position peaked at $8K in Q2 2015.
90 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2016.

Based on Magee Thomson Investment Partners's 13F filing for Q2 2016, filed 21 Jul 2016.